GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endo Inc (OTCPK:NDOI) » Definitions » Total Equity

Endo (NDOI) Total Equity : $1,252 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Endo Total Equity?

Endo's total equity for the quarter that ended in Dec. 2024 was $1,252 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Endo Total Equity Historical Data

The historical data trend for Endo's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Endo Total Equity Chart

Endo Annual Data
Trend Dec22 Dec23 Dec24
Total Equity
- -6,597.56 1,252.34

Endo Quarterly Data
Jun23 Sep23 Dec23 Apr24 Sep24 Dec24
Total Equity Get a 7-Day Free Trial - -6,597.56 - 1,600.56 1,252.34

Endo Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Endo's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=4352.901-3100.563
=1,252

Endo's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=4352.901-3100.563
=1,252

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Endo Total Equity Related Terms

Thank you for viewing the detailed overview of Endo's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Endo Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endo Inc (OTCPK:NDOI) » Definitions » Total Equity
Comparable Companies
AMRX SUPN DVAX AMPH KNSA ANIP PCRX HROW NIKA BGM ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB HKSE:03692
Traded in Other Exchanges
N/A
Address
9 Great Valley Parkway, Malvern, PA, USA, 19355
Website
https://www.endo.com
Endo Inc is a diversified pharmaceutical company. It has four reportable business segments: (1) Branded Pharmaceuticals, (2) Sterile Injectables, (3) Generic Pharmaceuticals and (4) International Pharmaceuticals. Branded Pharmaceuticals segment includes a variety of branded products in the therapeutic areas of urology, orthopedics, etc. Sterile Injectables segment consists of branded sterile injectable products such as ADRENALIN, VASOSTRICT and APLISOL, among others. Generic Pharmaceuticals segment includes a product portfolio including patches, solid oral extended-release products, etc. Key revenue is generated from International Pharmaceuticals segment includes a variety of specialty pharmaceutical products, including OTC products, sold outside the U.S.